Synthesis of new Hantzsch adducts showing Ca 2+ channel blockade capacity, cholinesterase inhibition and antioxidant power - Université de Franche-Comté Accéder directement au contenu
Article Dans Une Revue Future Medicinal Chemistry Année : 2021

Synthesis of new Hantzsch adducts showing Ca 2+ channel blockade capacity, cholinesterase inhibition and antioxidant power

Irene Pachón-Angona
  • Fonction : Auteur
Maciej Maj
Artur Wnorowski
Helene Martin
  • Fonction : Auteur
Krzysztof Jóźwiak

Résumé

Background: Alzheimer’s disease is a chronic neurodegenerative chronic disease with a heavy social and economic impact in our developed societies, which still lacks an efficient therapy. Method: This paper describes the Hantzsch multicomponent synthesis of twelve alkyl hexahydro-quinoline-3-carboxylates, 4a–l, along with the evaluation of their Ca 2+ channel blockade capacity, cholinesterase inhibition and antioxidant power. Results: Compound 4l showed submicromolar inhibition of butyrylcholinesterase, Ca 2+ channel antagonism and an antioxidant effect. Conclusion: Compound 4l is an interesting compound that deserves further investigation for Alzheimer’s disease therapy.
Fichier non déposé

Dates et versions

hal-03654559 , version 1 (28-04-2022)

Identifiants

Citer

Irene Pachón-Angona, Maciej Maj, Artur Wnorowski, Helene Martin, Krzysztof Jóźwiak, et al.. Synthesis of new Hantzsch adducts showing Ca 2+ channel blockade capacity, cholinesterase inhibition and antioxidant power. Future Medicinal Chemistry, 2021, 13 (20), pp.1717-1729. ⟨10.4155/fmc-2021-0176⟩. ⟨hal-03654559⟩

Collections

UNIV-FCOMTE
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More